For the Inventor, By the Inventor

Enter inventor name

Westfield, NJ, United States of America

Glenn J Gormley

This inventor holds 12 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1996-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glenn J Gormley. Retrieved from https://idiyas.com/inventor/glenn-j-gormley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12

% Patents Active = 91.7

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 101(Granted Patents)

Company Filing History:

12 out of 4,770

Merck + Co., Inc.

Years Active: 1996-2002

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6432971 - Method of prevention of prostatic carcinoma with 17&bgr;-N-monosubstituted-carbamoyl-4-aza-5&agr;-androst-1-en-3-ones (2002-08-13),

2. 6355649 - Method of treating seborrhea with 5-&agr; reductase inhibitors (2002-03-12),

3. 6268376 - Method of prevention of prostatic carcinoma with 17&bgr;-N-monosubstituted-carbamoyl-4-aza-5&agr;-androst-1-en-3-ones (2001-07-31),

4. 6174892 - Method of treating acne with 5-&agr; reductase inhibitors (2001-01-16),

5. 6046183 - Method of synergistic treatment for benign prostatic hyperplasia (2000-04-04),

6. 5994362 - Method of treatment for prostatic cancer (1999-11-30),

7. 5981543 - Method of treating androgenic alopecia with 5.alpha.-reductase inhibitors (1999-11-09),

8. 5824686 - Method of treating androgenic alopecia with 5-alpha reductase inhibitors (1998-10-20),

9. 5760046 - Method of treating androgenic alopecia with 5-.alpha.reductase inhibitors (1998-06-02),

10. 5753641 - Method of treatment for benign prostatic hyperplasia (1998-05-19),

11. 5629318 - Method of treatment of chronic prostatitis with (1997-05-13),

12. 5547957 - Method of treating androgenic alopecia with 5-.alpha. reductase (1996-08-20),

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…